familymednews.com
Ridiculous. That’s how Andrew Caprariello says his colleagues described his theory about multiple sclerosis (MS) back when he was doing his PhD in Ohio. Caprariello’s passion to explore controversial new theories about MS propelled him to seek out a postdoctoral fellowship with a like-minded thinker, whom he found in University of Calgary’s Dr. Peter Stys, a member of the Hotchkiss […]
Continue reading »
(HealthDay)—Children with multiple exposures to anesthesia before age 3 are more likely to develop adverse outcomes related to learning and attention, according to a recent study published in Anesthesiology. Danqing Hu, M.D., from the Mayo Clinic in Rochester, Minn., and colleagues retrospectively identified a cohort of children born between 1996 and 2000. Propensity matching selected children based on exposure or […]
Continue reading »
Exposure to a toxin primarily found in sheep could be linked to the development of multiple sclerosis (MS) in humans, new research suggests.Carried out by the University of Exeter and MS Sciences Ltd., the study has found that people with MS are more likely than other people to have antibodies against the Epsilon toxin, or ETX, – suggesting they may […]
Continue reading »
A phase I, first-in-human study led by The University of Texas MD Anderson Cancer Center reveals for the first time, an investigational drug that is effective and safe for patients with cancers caused by an alteration in the receptor tyrosine kinase known as RET. The drug appears to be promising as a potential therapy for RET-driven cancers, such as medullary […]
Continue reading »